- $1.33bn
- $2.72bn
- $588.90m
Brief: Alvotech and Teva Secure U.S. Settlement Date For AVT06
India's Dr Reddy's rises after EU marketing authorisation for osteoporosis biosimilar
Brief: UK High Court Rules In Favor Of Alvotech Paving Way For AVT06, Biosimilar To Eylea
U.S. STOCKS ON THE MOVE-Cummins, EPAM Systems, Qualcomm
U.S. STOCKS ON THE MOVE-Cummins, EPAM Systems, Qualcomm
Alvotech rises as UK clears new arthritis drug
U.S. STOCKS ON THE MOVE-Eli Lilly, Palantir, Tesla
U.S. STOCKS ON THE MOVE-Amazon, Nvidia, MongoDB
Alvotech drops after US FDA declines to approve arthritis drug
Brief: Kashiv Biosciences submits Biologics License Application to the U.S. FDA and receives European Medicines Agency acceptance for ADL-018
Indian drugmaker Dr Reddy's up on partnership to develop cancer immunotherapy
Brief: Dr Reddy's Says Alvotech And Dr. Reddy's Enter Into Collaboration
Brief: Alvotech, Dr. Reddy's Announce FDA Acceptance Of Biologic License Application
J&J sues Samsung Bioepis over Stelara biosimilar (updated)
J&J sues Samsung Bioepis over contract breach for Stelara biosimilar
U.S. STOCKS ON THE MOVE-MP Materials, Five9, Alphabet
Alvotech rallies after US biosimilar launch
Teva Pharma and Alvotech launch US biosimilar to J&J's Stelara (updated)
Teva Pharma and Alvotech launch Stelara biosimilar in US